AAAAAA

   
Results: 1-25 | 26-32
Results: 1-25/32
KARYOTYPIC CHANGES ASSOCIATED WITH SPONTANEOUS ACQUISITION AND LOSS OF TUMORIGENICITY IN A HUMAN TRANSFORMED BRONCHIAL EPITHELIAL-CELL LINE- EVIDENCE FOR IN-VIVO SELECTION OF TRANSFORMED CLONES
Authors: SCHILLER JH BITTNER G WU SQ MEISNER L
Citation: Jh. Schiller et al., KARYOTYPIC CHANGES ASSOCIATED WITH SPONTANEOUS ACQUISITION AND LOSS OF TUMORIGENICITY IN A HUMAN TRANSFORMED BRONCHIAL EPITHELIAL-CELL LINE- EVIDENCE FOR IN-VIVO SELECTION OF TRANSFORMED CLONES, In vitro cellular & developmental biology. Animal, 34(4), 1998, pp. 283-289
ROLE OF TAXANES IN LUNG-CANCER CHEMOTHERAPY
Authors: SCHILLER JH
Citation: Jh. Schiller, ROLE OF TAXANES IN LUNG-CANCER CHEMOTHERAPY, Cancer investigation, 16(7), 1998, pp. 471-477
LUNG-CANCER - THERAPEUTIC MODALITIES AND CYTOPROTECTION
Authors: SCHILLER JH
Citation: Jh. Schiller, LUNG-CANCER - THERAPEUTIC MODALITIES AND CYTOPROTECTION, Lung, 176(3), 1998, pp. 145-164
AN UPDATE ON NORTH-AMERICAN RANDOMIZED STUDIES IN NONSMALL CELL LUNG-CANCER
Authors: BUNN PA VOKES EE LANGER CJ SCHILLER JH
Citation: Pa. Bunn et al., AN UPDATE ON NORTH-AMERICAN RANDOMIZED STUDIES IN NONSMALL CELL LUNG-CANCER, Seminars in oncology, 25(4), 1998, pp. 2-10
PHASE IB TRIAL OF CHIMERIC ANTIDISIALOGANGLIOSIDE ANTIBODY PLUS INTERLEUKIN-2 FOR MELANOMA PATIENTS
Authors: ALBERTINI MR HANK JA SCHILLER JH KHORSAND M BORCHERT AA GAN J BECHHOFER R STORER B REISFELD RA SONDEL PM
Citation: Mr. Albertini et al., PHASE IB TRIAL OF CHIMERIC ANTIDISIALOGANGLIOSIDE ANTIBODY PLUS INTERLEUKIN-2 FOR MELANOMA PATIENTS, Clinical cancer research, 3(8), 1997, pp. 1277-1288
IMMUNOMODULATORY FUNCTION OF INTERFERON-GAMMA IN PATIENTS WITH METASTATIC MELANOMA - RESULTS OF A PHASE II-B TRIAL IN SUBJECTS WITH METASTATIC MELANOMA, ECOG STUDY E-4987
Authors: KIRKWOOD JM BRYANT J SCHILLER JH OKEN MM BORDEN EC WHITESIDE TL
Citation: Jm. Kirkwood et al., IMMUNOMODULATORY FUNCTION OF INTERFERON-GAMMA IN PATIENTS WITH METASTATIC MELANOMA - RESULTS OF A PHASE II-B TRIAL IN SUBJECTS WITH METASTATIC MELANOMA, ECOG STUDY E-4987, Journal of immunotherapy with emphasis on tumor immunology, 20(2), 1997, pp. 146-157
PHASE I IB STUDY OF IMMUNIZATION WITH AUTOLOGOUS TUMOR-CELLS TRANSFECTED WITH THE GM-CSF GENE BY PARTICLE-MEDIATED TRANSFER IN PATIENTS WITH MELANOMA OR SARCOMA/
Authors: MAHVI DM SONDEL PM YANG NS ALBERTINI MR SCHILLER JH HANK J HEINER J GAN J SWAIN W LOGRONO R
Citation: Dm. Mahvi et al., PHASE I IB STUDY OF IMMUNIZATION WITH AUTOLOGOUS TUMOR-CELLS TRANSFECTED WITH THE GM-CSF GENE BY PARTICLE-MEDIATED TRANSFER IN PATIENTS WITH MELANOMA OR SARCOMA/, Human gene therapy, 8(7), 1997, pp. 875-888
PRELIMINARY-RESULTS OF A RANDOMIZED COMPARATIVE PHASE-III TRIAL OF TOPOTECAN VERSUS CAV AS 2ND-LINE THERAPY OF SMALL-CELL LUNG-CANCER
Authors: CLARKE P SCHILLER JH VONPAWEL J KLEISBAUER JP DOBBS T CHRYSSON N DANE G HUDSON I DEWITTE M FIELDS SZ
Citation: P. Clarke et al., PRELIMINARY-RESULTS OF A RANDOMIZED COMPARATIVE PHASE-III TRIAL OF TOPOTECAN VERSUS CAV AS 2ND-LINE THERAPY OF SMALL-CELL LUNG-CANCER, European journal of cancer, 33, 1997, pp. 1032-1032
EFFECT OF AMIFOSTINE ON TOXICITIES ASSOCIATED WITH SEQUENTIAL CHEMOTHERAPY AND RADIATION-THERAPY FOR UNRESECTABLE NON-SMALL-CELL LUNG-CANCER - RESULTS OF A PHASE-II TRIAL
Authors: TANNEHILL SP MEHTA MP LARSON M STORER B PELLET J KINSELLA TJ SCHILLER JH
Citation: Sp. Tannehill et al., EFFECT OF AMIFOSTINE ON TOXICITIES ASSOCIATED WITH SEQUENTIAL CHEMOTHERAPY AND RADIATION-THERAPY FOR UNRESECTABLE NON-SMALL-CELL LUNG-CANCER - RESULTS OF A PHASE-II TRIAL, Journal of clinical oncology, 15(8), 1997, pp. 2850-2857
AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP PHASE-I TRIAL OF ALL-TRANS-RETINOIC ACID AND INTERFERON-ALPHA - E2Y92
Authors: SCHILLER JH NEUBERG D BURNS D RITCH P LARSON M LEVITT M DUTCHER J
Citation: Jh. Schiller et al., AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP PHASE-I TRIAL OF ALL-TRANS-RETINOIC ACID AND INTERFERON-ALPHA - E2Y92, Investigational new drugs, 15(4), 1997, pp. 319-324
TOPOTECAN IN SMALL-CELL LUNG-CANCER
Authors: SCHILLER JH
Citation: Jh. Schiller, TOPOTECAN IN SMALL-CELL LUNG-CANCER, Seminars in oncology, 24(6), 1997, pp. 27-33
LUNG-CANCER - REVIEW OF THE ECOG EXPERIENCE
Authors: SCHILLER JH CLEARY J JOHNSON D
Citation: Jh. Schiller et al., LUNG-CANCER - REVIEW OF THE ECOG EXPERIENCE, Oncology, 54(5), 1997, pp. 353-362
COMPARISON OF SPONTANEOUS AND INDUCED MUTATION-RATES IN AN IMMORTALIZED HUMAN BRONCHIAL EPITHELIAL-CELL LINE AND ITS TUMORIGENIC DERIVATIVE
Authors: WITTENKELLER JL STORER B BITTNER G SCHILLER JH
Citation: Jl. Wittenkeller et al., COMPARISON OF SPONTANEOUS AND INDUCED MUTATION-RATES IN AN IMMORTALIZED HUMAN BRONCHIAL EPITHELIAL-CELL LINE AND ITS TUMORIGENIC DERIVATIVE, Oncology, 54(4), 1997, pp. 335-341
CLINICAL AND IMMUNOLOGICAL EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR COADMINISTERED WITH INTERLEUKIN-2 - A PHASE IB STUDY
Authors: SCHILLER JH HANK JA KHORSAND M STORER B BORCHERT A HUSEBYMOORE K BURNS D WESLY O ALBERTINI MR WILDING G SONDEL PM
Citation: Jh. Schiller et al., CLINICAL AND IMMUNOLOGICAL EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR COADMINISTERED WITH INTERLEUKIN-2 - A PHASE IB STUDY, Clinical cancer research, 2(2), 1996, pp. 319-330
EASTERN COOPERATIVE GROUP TRIAL OF INTERFERON-GAMMA IN METASTATIC MELANOMA - AN INNOVATIVE STUDY DESIGN
Authors: SCHILLER JH PUGH M KIRKWOOD JM KARP D LARSON M BORDEN E
Citation: Jh. Schiller et al., EASTERN COOPERATIVE GROUP TRIAL OF INTERFERON-GAMMA IN METASTATIC MELANOMA - AN INNOVATIVE STUDY DESIGN, Clinical cancer research, 2(1), 1996, pp. 29-36
SYSTEMIC INTERLEUKIN-2 MODULATES THE ANTIIDIOTYPIC RESPONSE TO CHIMERIC ANTI-GD2 ANTIBODY IN PATIENTS WITH MELANOMA
Authors: ALBERTINI MR GAN J JAEGER P HANK JA STORER B SCHELL K RIVEST T SURFUS J REISFELD RA SCHILLER JH SONDEL PM
Citation: Mr. Albertini et al., SYSTEMIC INTERLEUKIN-2 MODULATES THE ANTIIDIOTYPIC RESPONSE TO CHIMERIC ANTI-GD2 ANTIBODY IN PATIENTS WITH MELANOMA, Journal of immunotherapy with emphasis on tumor immunology, 19(4), 1996, pp. 278-295
ANTI-RENAL-CELL CARCINOMA CHIMERIC ANTIBODY G250 FACILITATES ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY WITH IN-VITRO AND IN-VIVO INTERLEUKIN-2-ACTIVATED EFFECTORS
Authors: SURFUS JE HANK JA OOSTERWIJK E WELT S LINDSTROM MJ ALBERTINI MR SCHILLER JH SONDEL PM
Citation: Je. Surfus et al., ANTI-RENAL-CELL CARCINOMA CHIMERIC ANTIBODY G250 FACILITATES ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY WITH IN-VITRO AND IN-VIVO INTERLEUKIN-2-ACTIVATED EFFECTORS, Journal of immunotherapy with emphasis on tumor immunology, 19(3), 1996, pp. 184-191
PHASE-II STUDY OF TOPOTECAN IN PATIENTS WITH EXTENSIVE-STAGE SMALL-CELL CARCINOMA OF THE LUNG - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP TRIAL
Authors: SCHILLER JH KIM KM HUTSON P DEVORE R GLICK J STEWART J JOHNSON D
Citation: Jh. Schiller et al., PHASE-II STUDY OF TOPOTECAN IN PATIENTS WITH EXTENSIVE-STAGE SMALL-CELL CARCINOMA OF THE LUNG - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP TRIAL, Journal of clinical oncology, 14(8), 1996, pp. 2345-2352
RANDOMIZED TRIAL OF VINORELBINE COMPARED WITH FLUOROURACIL PLUS LEUCOVORIN IN PATIENTS WITH STAGE-IV NON-SMALL-CELL LUNG-CANCER
Authors: CRAWFORD J OROURKE M SCHILLER JH SPIRIDONITIS CH YANOVICH S OZER H LANGLEBEN A HUTCHINS L KOLETSKY A CLAMON G BURMAN S WHITE R HOHNEKER J
Citation: J. Crawford et al., RANDOMIZED TRIAL OF VINORELBINE COMPARED WITH FLUOROURACIL PLUS LEUCOVORIN IN PATIENTS WITH STAGE-IV NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 14(10), 1996, pp. 2774-2784
HIGH-DOSE CISPLATIN AND VINBLASTINE PLUS AMIFOSTINE FOR METASTATIC NONSMALL CELL LUNG-CANCER
Authors: SCHILLER JH
Citation: Jh. Schiller, HIGH-DOSE CISPLATIN AND VINBLASTINE PLUS AMIFOSTINE FOR METASTATIC NONSMALL CELL LUNG-CANCER, Seminars in oncology, 23(4), 1996, pp. 78-82
CLINICAL AND IMMUNOLOGICAL EFFECTS OF TREATMENT WITH MURINE ANTI-CD3 MONOCLONAL-ANTIBODY ALONG WITH INTERLEUKIN-2 IN PATIENTS WITH CANCER
Authors: HANK JA ALBERTINI M WESLY OH SCHILLER JH BORCHERT A MOORE K BECHHOFER R STORER B GAN J GAMBACORTI C SOSMAN J SONDEL PM
Citation: Ja. Hank et al., CLINICAL AND IMMUNOLOGICAL EFFECTS OF TREATMENT WITH MURINE ANTI-CD3 MONOCLONAL-ANTIBODY ALONG WITH INTERLEUKIN-2 IN PATIENTS WITH CANCER, Clinical cancer research, 1(5), 1995, pp. 481-491
AMIFOSTINE (A), CISPLATIN (C), VINBLASTINE (V) - A HIGHLY-ACTIVE REGIMEN FOR NON-SMALL-CELL LUNG-CANCER (NSCLC)
Authors: SCHILLER JH LARSON ML LARSON MH PHARO L MEHTA M STORER B
Citation: Jh. Schiller et al., AMIFOSTINE (A), CISPLATIN (C), VINBLASTINE (V) - A HIGHLY-ACTIVE REGIMEN FOR NON-SMALL-CELL LUNG-CANCER (NSCLC), European journal of cancer, 31A, 1995, pp. 1106-1106
CONCOMITANT ADMINISTRATION OF INTERLEUKIN-2 PLUS TUMOR-NECROSIS-FACTOR IN ADVANCED NONSMALL CELL LUNG-CANCER
Authors: SCHILLER JH MORGANIHRIG C LEVITT ML
Citation: Jh. Schiller et al., CONCOMITANT ADMINISTRATION OF INTERLEUKIN-2 PLUS TUMOR-NECROSIS-FACTOR IN ADVANCED NONSMALL CELL LUNG-CANCER, American journal of clinical oncology, 18(1), 1995, pp. 47-51
PROGNOSIS WITH ASYMPTOMATIC PULMONARY NODULES
Authors: MEHTA M SCHILLER JH
Citation: M. Mehta et Jh. Schiller, PROGNOSIS WITH ASYMPTOMATIC PULMONARY NODULES, JAMA, the journal of the American Medical Association, 274(4), 1995, pp. 358-358
LOSS OF THE TUMORIGENIC PHENOTYPE WITH IN-VITRO, BUT NOT IN-VIVO, PASSAGING OF A NOVEL SERIES OF HUMAN BRONCHIAL EPITHELIAL-CELL LINES - POSSIBLE ROLE OF AN ALPHA-5 BETA-1-INTEGRIN-FIBRONECTIN INTERACTION/
Authors: SCHILLER JH BITTNER G
Citation: Jh. Schiller et G. Bittner, LOSS OF THE TUMORIGENIC PHENOTYPE WITH IN-VITRO, BUT NOT IN-VIVO, PASSAGING OF A NOVEL SERIES OF HUMAN BRONCHIAL EPITHELIAL-CELL LINES - POSSIBLE ROLE OF AN ALPHA-5 BETA-1-INTEGRIN-FIBRONECTIN INTERACTION/, Cancer research, 55(24), 1995, pp. 6215-6221
Risultati: 1-25 | 26-32